CUSIP 10806XAB8NOTE 2.500% 3/1BBIOQ4 2025
Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).